BD business split ‘may prefigure’ life sciences division selloff
Becton, Dickinson (BD) management’s board approval to pursue a plan to separate BD's Biosciences and Diagnostic Solutions business from the …
Post
-
-
Senseonics files for Eversense 365 CE Mark registration
Senseonics has filed to obtain CE Mark registration for its one-year continuous glucose monitoring (CGM) system, Eversense 365. The CE Mark …
-
“Still waiting for a full response” – UK government lags on mesh scandal action
The UK Government is facing calls to properly redress women impacted by the mesh scandal, a year after a report …
-
43rd Annual JP Morgan Healthcare Conference 2025 OR
The 43rd Annual JP Morgan Healthcare Conference took place in San Francisco, California on January 13–16, 2025. This annual conference is …
-
AISAP and Amavita partner to bring POCUS to underserved Floridian communities
AISAP has partnered with US-based Amavita Heart and Vascular Health in a move set to bring its AI-powered AISAP CARDIO …
-
FDA fast tracks Bracco’s BR55 for Crohn’s disease bowel inflammation detection
The US Food and Drug Administration (FDA) has granted fast track designation for the development of Bracco Imaging's molecular imaging …
-
Wellumio’s portable MRI device trial enrols first subject in Australia
Wellumio has enrolled the first subject in the Portable MRI study of its magnetic resonance imaging (MRI) device, 'Axana' 0.1T, …
-
Novartis and Dawn Health introduce breast cancer support app
Novartis, in partnership with Dawn Health, introduced Cora BC, a digital solution designed to support individuals with breast cancer on …
-
Farapulse boosts Boston Scientific’s Q4 electrophysiology sales by 172%
Boston Scientific reported that electrophysiology sales grew 172% in Q4 2024, driven by an uptake of its Farapulse pulsed field …
-
CereVasc scores safety and efficacy win in hydrocephalus treatment pilot study
CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients with …
-
Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’ regulatory …
-
Newronika secures FDA’s IDE to begin adaptive deep brain stimulation system trial
Newronika has received an investigational device exemption (IDE) for its adaptive deep brain stimulation (DBS) system from the US Food …
-
ScreenPoint’s AI breast cancer screening tool hits detection success in new study
ScreenPoint Medical has demonstrated the value of its AI-powered Transpara: Breast AI screening tool in a new study. The Netherlands-based company’s …
-
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay
The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 OncoSignature assay designed to …
-
Auxilium’s 3D printer builds medical devices on the International Space Station
A 3D printer developed by Auxilium Biotechnologies has created medical devices on the International Space Station (ISS) as science attempts …
